Related Experiment Video
Updated: Sep 21, 2026

Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
[Decrease in the serum level of the C3 complement component in noninsulin dependent diabetes of recent onset]
Insights
Recent-onset insulin-dependent diabetes (IDD) shows decreased complement component C3, possibly due to increased consumption. Long-standing IDD patients did not exhibit significant complement variations compared to controls.
Area of Science:
- Immunology
- Endocrinology
- Clinical Chemistry
Context:
- Investigates complement system alterations in diabetes mellitus.
- Focuses on complement components C3, C4, and C3A.
- Compares recent-onset and long-standing insulin-dependent diabetes (IDD) patients with non-diabetic controls.
Purpose:
- To measure and compare plasma levels of complement components C3, C4, and C3A in different diabetes mellitus groups.
- To explore potential correlations between complement variations and immunological markers (islet cell antibodies, HLA antigens) in recent-onset IDD.
Summary:
- A significant decrease in complement component C3 and a mild increase in C3A were observed in recent-onset IDD patients.
- These complement variations in recent-onset IDD did not correlate with IgG-islet cell antibodies, C3-fixing islet cell antibodies, or A-B HLA antigens.
- No significant differences in C3, C4, or C3A levels were found between long-standing IDD patients and non-diabetic controls.
Impact:
- Suggests that decreased C3 in recent-onset IDD may result from increased complement consumption.
- Hypothesizes that complement consumption could be linked to the insulitis process or circulating immune complexes in early diabetes.
- Highlights potential roles of the complement system in the pathogenesis of early-stage insulin-dependent diabetes.
Abstract:
Complement components C3, C4 and C3A were measured by immuno-diffusion in plasma of 36 recent onset insulin-dependent diabetics (IDD) and compared to plasma complement levels of 19 long-standing IDD and 18 non diabetic controls. A significant decrease of C3 and a mild increase of C3A was found in recent-onset diabetes group. However these variations could not be correlated with IgG-islet cell antibodies, C3--fixing islet cell antibodies or A--B HLA antigens. No significant difference was found between long-standing IDD and controls for the 3 complement components. In conclusion, the decrease of C3, found in 30% of recent onset IDD, might be due to increase complement consumption either by the insulitis process or by circulating immune complexes.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes II: Pathophysiology
Type I Diabetes III: Clinical Manifestations
Type II Diabetes II: Pathophysiology
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetic Nephropathy

